glp-1 agonist drugs Receptor Agonists and Other List of GLP-1 Receptor Agonists

doi: 10.1056/NEJMoa2403347 [DOI] [PubMed] [Google Scholar] 257

It is derived from exendin-4 through N-terminal truncation and shares 53% sequence homology with native GLP-1 39

The updated model emphasizes that aging is not driven by a single mechanism, but emerges from a network of interacting biological systems that link molecular damage to systemic physiological decline

The proportion of patients who achieved the HbA1c goal ranged from 25.9% (95% CI 18.534.9) with alpha -glucosidase inhibitors to 63.2% (54.171.5) with the long-acting GLP-1 analogue

Beyond T2D and obesity, semaglutide was also applied for other indications such as cardiovascular disease, fatty liver, chronic kidney disease, all of which have progressed to Phase 3, expanding the influence of GLP-1RAs into more medical fields

[DOI] [PMC free article] [PubMed] [Google Scholar] [221].Deryabina MA, Daugaard JR, Knudsen CB, Shelton PT, Fog JU, Jessen L, Noerregaard P, Pharmacokinetics and Pharmacodynamics of GLP-1-GIP Receptor Dual Agonist Peptides: From Once-Daily to Once-Weekly, Diabetes, 64 (2015) A534A534